iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
205.96
-4.57 (-2.17%)
At close: Oct 1, 2026, 4:00 PM EDT
205.95
-0.02 (-0.01%)
After-hours: Oct 1, 2026, 7:30 PM EDT
IBB Holdings Information
IBB is an equity ETF with a total of 248 individual holdings. The top holdings are Gilead Sciences stock at 8.08%, Amgen at 7.78%, Vertex Pharmaceuticals at 7.62%, Regeneron Pharmaceuticals at 5.28%, and Moderna at 4.94%.
Total Holdings
248
Top 10 Percentage
49.33%
Asset Class
Equity
ETF Category
Health
Assets
10.64B
PE Ratio
25.20
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences, Inc. | 8.08% |
| 2 | AMGN | Amgen Inc. | 7.78% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.62% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.28% |
| 5 | MRNA | Moderna, Inc. | 4.94% |
| 6 | NTRA | Natera, Inc. | 3.91% |
| 7 | ARGX | argenx SE | 3.74% |
| 8 | ILMN | Illumina, Inc. | 2.89% |
| 9 | RVMD | Revolution Medicines, Inc. | 2.78% |
| 10 | BIIB | Biogen Inc. | 2.33% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.31% |
| 12 | ONC | BeOne Medicines AG | 2.16% |
| 13 | INSM | Insmed Incorporated | 1.72% |
| 14 | INCY | Incyte Corporation | 1.71% |
| 15 | UTHR | United Therapeutics Corporation | 1.58% |
| 16 | GMAB | Genmab A/S | 1.39% |
| 17 | ROIV | Roivant Sciences Ltd. | 1.35% |
| 18 | NBIX | Neurocrine Biosciences, Inc. | 1.00% |
| 19 | ASND | Ascendis Pharma A/S | 0.99% |
| 20 | MEDP | Medpace Holdings, Inc. | 0.98% |
| 21 | EXEL | Exelixis, Inc. | 0.98% |
| 22 | CRL | Charles River Laboratories International, Inc. | 0.98% |
| 23 | HALO | Halozyme Therapeutics, Inc. | 0.87% |
| 24 | TWST | Twist Bioscience Corporation | 0.86% |
| 25 | BBIO | BridgeBio Pharma, Inc. | 0.81% |
As of Sep 30, 2026